Compare ASMB & ACNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASMB | ACNB |
|---|---|---|
| Founded | 2005 | 1857 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 553.6M | 468.6M |
| IPO Year | 2010 | N/A |
| Metric | ASMB | ACNB |
|---|---|---|
| Price | $30.81 | $48.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | $43.40 | ★ $49.50 |
| AVG Volume (30 Days) | ★ 150.8K | 27.7K |
| Earning Date | 11-10-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 3.13% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.34 |
| Revenue | $37,191,000.00 | ★ $136,676,000.00 |
| Revenue This Year | $33.33 | $41.56 |
| Revenue Next Year | N/A | $4.18 |
| P/E Ratio | ★ N/A | $14.52 |
| Revenue Growth | ★ 31.30 | 28.45 |
| 52 Week Low | $7.75 | $35.70 |
| 52 Week High | $39.71 | $53.41 |
| Indicator | ASMB | ACNB |
|---|---|---|
| Relative Strength Index (RSI) | 39.55 | 43.81 |
| Support Level | $31.73 | $46.86 |
| Resistance Level | $34.69 | $49.11 |
| Average True Range (ATR) | 2.07 | 1.17 |
| MACD | -0.36 | -0.48 |
| Stochastic Oscillator | 2.50 | 23.13 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.